210 related articles for article (PubMed ID: 25411763)
1. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
Valencia JC; Steagall WK; Zhang Y; Fetsch P; Abati A; Tsukada K; Billings E; Hearing VJ; Yu ZX; Pacheco-Rodriguez G; Moss J
Chest; 2015 Mar; 147(3):771-777. PubMed ID: 25411763
[TBL] [Abstract][Full Text] [Related]
2. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
3. The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.
Pacheco-Rodriguez G; Moss J
Crit Rev Immunol; 2010; 30(4):387-94. PubMed ID: 20666708
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.
Steagall WK; Pacheco-Rodriguez G; Glasgow CG; Ikeda Y; Lin JP; Zheng G; Moss J
Am J Pathol; 2013 Sep; 183(3):938-50. PubMed ID: 23867796
[TBL] [Abstract][Full Text] [Related]
6. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
[TBL] [Abstract][Full Text] [Related]
7. TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.
Pacheco-Rodriguez G; Steagall WK; Crooks DM; Stevens LA; Hashimoto H; Li S; Wang JA; Darling TN; Moss J
Cancer Res; 2007 Nov; 67(21):10573-81. PubMed ID: 17975002
[TBL] [Abstract][Full Text] [Related]
8. Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis.
Lesma E; Chiaramonte E; Ancona S; Orpianesi E; Di Giulio AM; Gorio A
Biomed Res Int; 2015; 2015():315240. PubMed ID: 25699271
[TBL] [Abstract][Full Text] [Related]
9. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
11. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.
Krymskaya VP
Proc Am Thorac Soc; 2008 Jan; 5(1):119-26. PubMed ID: 18094094
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.
Schiavina M; Di Scioscio V; Contini P; Cavazza A; Fabiani A; Barberis M; Bini A; Altimari A; Cooke RM; Grigioni WF; D'Errico-Grigioni A
Am J Respir Crit Care Med; 2007 Jul; 176(1):96-8. PubMed ID: 17431222
[TBL] [Abstract][Full Text] [Related]
13. Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change.
Pileri SA; Cavazza A; Schiavina M; Zompatori M; Pederzoli M; Goldfischer M; Sabattini E; Ascani S; Pasquinelli G; Bonetti F; Colby TV
Histopathology; 2004 Feb; 44(2):156-63. PubMed ID: 14764059
[TBL] [Abstract][Full Text] [Related]
14. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
[TBL] [Abstract][Full Text] [Related]
16. Angiomyomatous hamartoma of lymph nodes, revisited: clinicopathologic study of 21 cases, emphasizing its distinction from lymphangioleiomyomatosis of lymph nodes.
Moh M; Sangoi AR; Rabban JT
Hum Pathol; 2017 Oct; 68():175-183. PubMed ID: 28899738
[TBL] [Abstract][Full Text] [Related]
17. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Matsui K; Takeda K; Yu ZX; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Feb; 124(2):267-75. PubMed ID: 10656737
[TBL] [Abstract][Full Text] [Related]
18. Adoptive T-Cell Transfer to Treat Lymphangioleiomyomatosis.
Han F; Dellacecca ER; Barse LW; Cosgrove C; Henning SW; Ankney CM; Jaishankar D; Yemelyanov A; Krymskaya VP; Dilling DF; Le Poole IC
Am J Respir Cell Mol Biol; 2020 Jun; 62(6):793-804. PubMed ID: 32078336
[TBL] [Abstract][Full Text] [Related]
19. Regional proliferation of HMB-45-positive clear cells of the lung with lymphangioleiomyomatosislike distribution, replacing the lobes with multiple cysts and a nodule.
Hironaka M; Fukayama M
Am J Surg Pathol; 1999 Oct; 23(10):1288-93. PubMed ID: 10524532
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic involvement in lymphangioleiomyomatosis.
Glasgow CG; Taveira-Dasilva AM; Darling TN; Moss J
Ann N Y Acad Sci; 2008; 1131():206-14. PubMed ID: 18519973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
